A Phase II Study of the Efficacy and Safety of Irinotecan in Combination with Capecitabine as First-Line Chemotherapy in Asian Patients with Inoperable Hepatocellular Carcinoma (HCC)
Invited conference paper presented and published in conference proceedings

香港中文大學研究人員

其它資訊
著者MOK Shu Kam Tony
會議名稱29th ESMO Congress
會議開始日01.11.2004
會議國家/地區奧地利
會議論文集題名29th ESMO Congress
詳細描述organized by European Society for Medical Oncology,
出版年份2004
月份11
出版地Austria, Vienna
頁次1
語言英式英語
關鍵詞HCC; Irinotecan; Capecitabine

上次更新時間 2018-23-01 於 07:48